AstraZeneca Aktie
171,20
EUR
+0,55
EUR
+0,32
%
204,52
USD
-0,24
USD
-0,12
%
Werbung
AstraZeneca Aktie Analyse
| 12.11.21 | AstraZeneca Buy | UBS AG | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |
| 02.11.21 | AstraZeneca Buy | UBS AG | |
| 26.10.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 25.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 21.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.10.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 19.10.21 | AstraZeneca Buy | UBS AG | |
| 18.10.21 | AstraZeneca Buy | Kepler Cheuvreux | |
| 15.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.10.21 | AstraZeneca Buy | UBS AG | |
| 13.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.10.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 11.10.21 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 28.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.09.21 | AstraZeneca Overweight | Barclays Capital | |
| 24.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.09.21 | AstraZeneca Buy | UBS AG | |
| 24.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 23.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.21 | AstraZeneca Overweight | Morgan Stanley | |
| 15.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.09.21 | AstraZeneca Buy | UBS AG | |
| 10.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 02.09.21 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 26.08.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.08.21 | AstraZeneca Buy | UBS AG | |
| 16.08.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.08.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.08.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.08.21 | AstraZeneca Buy | UBS AG | |
| 30.07.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.07.21 | AstraZeneca Buy | UBS AG | |
| 21.07.21 | AstraZeneca Buy | UBS AG | |
| 15.07.21 | AstraZeneca Buy | UBS AG | |
| 14.07.21 | AstraZeneca Buy | UBS AG | |
| 12.07.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 07.07.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.06.21 | AstraZeneca buy | UBS AG | |
| 15.06.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.06.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.06.21 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung